Adcetris (brentuximab vedotin)

pCPA File Number: 21264
Negotiation Status:
Active Negotiation
Indication(s):
Peripheral T-Cell Lymphoma
Sponsor/Manufacturer:
Seattle Genetics Inc.
CADTH Project Number:
pCODR 10199
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable